Observational studyClinical and experimental medicine2023

Systemic immunity markers are associated with clinical outcomes of atezolizumab treatment in patients with triple-negative advanced breast cancer: a retrospective multicenter observational study.

Shogo Nakamoto et al.PubMed ↗Publisher ↗

No numbers read from the abstract.